Christien Kluwe, MD, PhD

Assistant Professor

Dr. Christien Kluwe is an Assistant Professor in the Department of Radiation Oncology at Vanderbilt-Ingram Cancer Center.  He graduated with combined MD and PhD degrees from the University of Texas, focusing his research on directed evolution and computational design of engineered antibodies.  During his residency in Radiation Oncology at Vanderbilt University Medical Center, he was awarded a Holman Fellowship to study the interaction of metabolism and radiation therapy in lung cancer.  Dr. Kluwe completed his training with the title of Chief Resident and joined the faculty at Vanderbilt. 

Dr. Kluwe specializes in the treatment of genitourinary and thoracic malignancies.  His clinical research is concentrated on the implementation of AI-driven adaptive radiotherapy on the Ethos platform in our Nashville and Wilson County hospitals.  He currently co-serves as Director of Adaptive Radiotherapy at VUMC with medical physicist Dr. Adam Yock.


  • Chief Resident, Radiation Oncology, Vanderbilt University, 2019-2020
  • ASTRO Resident Seed Grant, Vanderbilt University, 2017-2019
  • ABR Leonard B. Holman Research Fellowship, Vanderbilt University, 2016-2020


  • Residency, Vanderbilt University Medical Center, Nashville, TN
  • Internship, University of Texas Medical Branch Galveston, Galveston, TX
  • M.D., University of Texas Medical Branch Galveston, Galveston, TX
  • Ph.D., Institute for Cellular and Molecular Biology at the University of Texas at Austin, Austin, TX
  • B.S., University of Miami, Miami, FL